ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Ann Thorac Surg 2008;86:115-122. doi:10.1016/j.athoracsur.2008.03.062
© 2008 The Society of Thoracic Surgeons

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Matthias Siepe
Torsten Doenst
Friedhelm Beyersdorf
Christian Schlensak
Right arrow Permission Requests
Google Scholar
Right arrow Articles by Siepe, M.
Right arrow Articles by Schlensak, C.
PubMed
Right arrow Articles by Siepe, M.
Right arrow Articles by Schlensak, C.
Related Collections
Right arrow Extracorporeal circulation


Original Articles: Adult Cardiac

Pulsatile Pulmonary Perfusion During Cardiopulmonary Bypass Reduces the Pulmonary Inflammatory Response

Matthias Siepe, MDa,*, Ulrich Goebel, MDb,*, Anne Mecklenburg, BSb, Torsten Doenst, MDa, Christoph Benk, BSa, Philipp Stein, MDb, Friedhelm Beyersdorf, MDa, Torsten Loop, MDb, Christian Schlensak, MDa,*

a Department of Cardiovascular Surgery, University Medical Center, Freiburg, Germany
b Department of Anesthesiology and Critical Care Medicine, University Medical Center, Freiburg, Germany

Accepted for publication March 25, 2008.

* Address correspondence to Dr Schlensak, Department of Cardiovascular Surgery, University Medical Center Freiburg, Hugstetter Str 55, Freiburg, 79106, Germany (Email: christian.schlensak{at}uniklinik-freiburg.de).

Background: Pulmonary dysfunction presumably linked to an inflammatory response is frequent after cardiac operations using cardiopulmonary bypass (CPB) and pulmonary hypoperfusion. We previously demonstrated that active perfusion of the lungs during CPB reduces ischemic lung injury. We now hypothesized that avoiding ischemia of the lungs during CPB by active pulmonary perfusion would decrease pulmonary inflammatory response.

Methods: Pigs were randomized to a control group with CPB for 120 minutes, followed by 120 minutes of postbypass reperfusion, or to the study groups where animals underwent active pulmonary perfusion with pulsatile or nonpulsatile perfusion during CPB (n = 7 in each group). Activation of transcription factor activity (nuclear factor [NF]-{kappa}B and activating protein [AP]-1) was determined by electrophoretic mobility shift assay. Levels of proinflammatory protein expression (interleukin [IL]-1, IL-6, and tumor necrosis factor [TNF]-{alpha}) were quantified by enzyme-linked immunoabsorbent assay. Caspase-3 activity was measured using a fluorogenic assay.

Results: The activation of transcription factor AP-1 and NF-{kappa}B was reduced in the pulsatile pulmonary perfusion group. The caspase-3 activity and the expression of IL-1, IL-6, and TNF-{alpha} revealed a significant decrease in the pulsatile and nonpulsatile pulmonary perfusion groups. Animals of the pulsatile pulmonary perfusion group showed significantly reduced IL-6 expression and caspase-3 activity compared with the nonpulsatile pulmonary perfusion group.

Conclusions: Active pulmonary perfusion reduces the inflammatory response and apoptosis in the lungs observed during conventional CPB. This effect is greatest when pulmonary perfusion is performed with pulsatility. The reduction in cytokine expression by pulsatile pulmonary perfusion might be mediated by AP-1 and NF-{kappa}B.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 by The Society of Thoracic Surgeons.